These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25812853)

  • 1. Enhanced cancer cell killing of a Pt(IV) prodrug promoted by outer-sphere coordination with polyethyleneimines.
    Garaikoetxea Arguinzoniz A; Gómez Blanco N; Ansorena Legarra P; Mareque-Rivas JC
    Dalton Trans; 2015 Apr; 44(16):7135-8. PubMed ID: 25812853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
    Yap SQ; Chin CF; Hong Thng AH; Pang YY; Ho HK; Ang WH
    ChemMedChem; 2017 Feb; 12(4):300-311. PubMed ID: 28028938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-chemotherapeutic platinum(IV) prodrugs of cisplatin as multimodal anticancer agents.
    Wong DY; Yeo CH; Ang WH
    Angew Chem Int Ed Engl; 2014 Jun; 53(26):6752-6. PubMed ID: 24844571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodinuclear Pt(iv)-Ru(ii) anticancer prodrugs to combat both drug resistance and tumor metastasis.
    Ma L; Ma R; Wang Z; Yiu SM; Zhu G
    Chem Commun (Camb); 2016 Sep; 52(71):10735-8. PubMed ID: 27506281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation.
    Yuan Y; Chen Y; Tang BZ; Liu B
    Chem Commun (Camb); 2014 Apr; 50(29):3868-70. PubMed ID: 24589580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced cytotoxicity of gold porphyrin complexes after inclusion in cyclodextrin scaffolds adsorbed on polyethyleneimine-coated gold nanoparticles.
    Granet R; Faure R; Ndong Ntoutoume GM; Mbakidi JP; Leger DY; Liagre B; Sol V
    Bioorg Med Chem Lett; 2019 May; 29(9):1065-1068. PubMed ID: 30852085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum(IV) prodrug conjugated Pd@Au nanoplates for chemotherapy and photothermal therapy.
    Shi S; Chen X; Wei J; Huang Y; Weng J; Zheng N
    Nanoscale; 2016 Mar; 8(10):5706-13. PubMed ID: 26900670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.
    Ravera M; Gabano E; Zanellato I; Fregonese F; Pelosi G; Platts JA; Osella D
    Dalton Trans; 2016 Mar; 45(12):5300-9. PubMed ID: 26903367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-Specific, Intracellular, Reductive Activation of Anticancer Pt
    Reshetnikov V; Daum S; Mokhir A
    Chemistry; 2017 Apr; 23(24):5678-5681. PubMed ID: 28319647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pt(IV) complexes as prodrugs for cisplatin.
    Shi Y; Liu SA; Kerwood DJ; Goodisman J; Dabrowiak JC
    J Inorg Biochem; 2012 Feb; 107(1):6-14. PubMed ID: 22169035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
    Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
    ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copper-free click-chemistry platform to functionalize cisplatin prodrugs.
    Pathak RK; McNitt CD; Popik VV; Dhar S
    Chemistry; 2014 Jun; 20(23):6861-5. PubMed ID: 24756923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate.
    Qiao X; Gao YY; Zheng LX; Ding XJ; Xu LW; Hu JJ; Gao WZ; Xu JY
    Eur J Med Chem; 2021 Nov; 223():113730. PubMed ID: 34388483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
    Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
    Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Polymer Coating of Gold Nanoparticles on Oxidative Stress and DNA Damage.
    Sen GT; Ozkemahli G; Shahbazi R; Erkekoglu P; Ulubayram K; Kocer-Gumusel B
    Int J Toxicol; 2020; 39(4):328-340. PubMed ID: 32483993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled synthesis of PEI-coated gold nanoparticles using reductive catechol chemistry for siRNA delivery.
    Lee Y; Lee SH; Kim JS; Maruyama A; Chen X; Park TG
    J Control Release; 2011 Oct; 155(1):3-10. PubMed ID: 20869409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyanide Bridged Platinum-Iron Complexes as Cisplatin Prodrug Systems: Design and Computational Study.
    Kaspi-Kaneti AW; Bhandari S; Schubert A; Huang SD; Dunietz BD
    Chemphyschem; 2021 Jan; 22(1):106-111. PubMed ID: 33098742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery.
    Song WJ; Du JZ; Sun TM; Zhang PZ; Wang J
    Small; 2010 Jan; 6(2):239-46. PubMed ID: 19924738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold nanorods for platinum based prodrug delivery.
    Min Y; Mao C; Xu D; Wang J; Liu Y
    Chem Commun (Camb); 2010 Nov; 46(44):8424-6. PubMed ID: 20936244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.
    Shi Y; Goodisman J; Dabrowiak JC
    Inorg Chem; 2013 Aug; 52(16):9418-26. PubMed ID: 23889547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.